Increasingly, Japanese biotech and pharmaceutical companies are expanding their activities into the U.S., Europe and other markets. At the same time, more and more multinationals are discovering the potential of the Japanese market. With nine facilities in Japan, Quintiles Japan has developed the special expertise required of a global service provider to help you achieve your goals in the new health landscape.

Quintiles Japan offers the following key services for product commercialization: